Breaking News

List Biotherapeutics Invests Over $125M to Establish New Facility in Fishers, IN

The objective of the new facility is to manufacture live biotherapeutic products for Phase 3 clinical trials & commercial use.

Author Image

By: Charlie Sternberg

Associate Editor

List Biotherapeutics Inc., whose parent company is South Korea-based Genome & Company, has invested more than $125 million in the city of Fishers, Indiana to establish a new 110,000 square foot contract manufacturing organization (CMO) facility on 15 acres in the Fishers Life Science & Innovation Park.   The company plans to hire 210 employees in Fishers in the areas of biologics manufacturing and quality and regulatory compliance after commissioning the facility by the end of 2023 whi...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters